We are live on ! Find out more
CORT icon

Corcept Therapeutics

212 hedge funds and large institutions have $1.45B invested in Corcept Therapeutics in 2018 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 66 increasing their positions, 68 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 32

12% more funds holding

Funds holding: 190212 (+22)

10% more call options, than puts

Call options by funds: $10.8M | Put options by funds: $9.82M

3% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 68

1.33% less ownership

Funds ownership: 77.88%76.55% (-1.3%)

10% less capital invested

Capital invested by funds: $1.61B → $1.45B (-$159M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
212
Holders Change
+22
Holders Change %
+11.58%
% of All Funds
4.86%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
57
Increased
66
Reduced
68
Closed
32
Calls
$10.8M
Puts
$9.82M
Net Calls
+$1.02M
Net Calls Change
-$1.53M
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
76
Dupont Capital Management
Delaware
$1.53M -$458K -24,694 -21%
State of Wisconsin Investment Board
77
State of Wisconsin Investment Board
Wisconsin
$1.51M +$352K +19,000 +26%
PSUF
78
People's United Financial
Connecticut
$1.5M
VRS
79
Virginia Retirement Systems
Virginia
$1.39M -$228K -12,300 -13%
HIM
80
Hillsdale Investment Management
Ontario, Canada
$1.32M -$185K -10,000 -11%
KC
81
Kepos Capital
New York
$1.31M +$1.48M +79,937 New
Los Angeles Capital Management
82
Los Angeles Capital Management
California
$1.26M -$1.35M -72,960 -49%
CI
83
Cavalier Investments
Georgia
$1.25M
BC
84
Birchview Capital
Vermont
$1.24M -$361K -19,500 -21%
CIA
85
Capital Impact Advisors
Massachusetts
$1.22M -$72.2K -3,896 -5%
VOYA Investment Management
86
VOYA Investment Management
Georgia
$1.2M -$27.2K -1,466 -2%
PNC Financial Services Group
87
PNC Financial Services Group
Pennsylvania
$1.19M -$3.95M -213,351 -75%
ECM
88
ETrade Capital Management
Virginia
$1.13M +$1.27M +68,744 New
New York State Teachers Retirement System (NYSTRS)
89
New York State Teachers Retirement System (NYSTRS)
New York
$1.12M +$556K +30,007 +78%
State of Tennessee, Department of Treasury
90
State of Tennessee, Department of Treasury
Tennessee
$1.11M +$1.25M +67,679 New
1CM
91
1492 Capital Management
Wisconsin
$1.06M -$98.7K -5,328 -8%
Thrivent Financial for Lutherans
92
Thrivent Financial for Lutherans
Minnesota
$1.06M +$133K +7,166 +13%
UBS AM
93
UBS AM
Illinois
$1.05M +$127K +6,850 +12%
CAM
94
ClariVest Asset Management
California
$1.05M -$1.69M -91,300 -59%
TPSF
95
Texas Permanent School Fund
Texas
$1.04M +$392K +21,167 +50%
ZCM
96
Zebra Capital Management
Connecticut
$1.03M +$159K +8,587 +16%
USAA
97
United Services Automobile Association
Texas
$1.02M +$205K +11,041 +22%
Public Sector Pension Investment Board (PSP Investments)
98
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.01M +$29.6K +1,600 +3%
SO
99
STRS Ohio
Ohio
$1M
Rafferty Asset Management
100
Rafferty Asset Management
New York
$974K +$1.1M +59,201 New

CORT Hedge Fund Activity: Q1 2018 in Review

212 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q1 2018, worth a combined $1.45B — down 9.9% from $1.61B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new CORT positions and 32 closed out — a net gain of 25 holders — while 66 added to existing stakes and 68 trimmed.

The largest buyer was BlackRock, adding an estimated $27.9M. The largest seller was Prudential Financial, cutting an estimated $23.4M.

  • 212 institutional investors held Corcept Therapeutics (CORT) as of Q1 2018, up from 190 in Q4 2017.
  • Funds reported $1.45B of Corcept Therapeutics stock for Q1 2018, down 9.9% quarter-over-quarter.
  • 57 funds opened new Corcept Therapeutics positions in Q1 2018 and 32 closed out, a net change of +25 holders.
  • The largest Corcept Therapeutics buyer in Q1 2018 was BlackRock, an estimated $27.9M added.
  • The largest Corcept Therapeutics seller in Q1 2018 was Prudential Financial, an estimated $23.4M sold.

Based on aggregated 13F filings for Q1 2018.